144 related articles for article (PubMed ID: 24112388)
1. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
Yan YR; Xie Q; Li F; Zhang Y; Ma JW; Xie SM; Li HY; Zhong XY
Neuropathology; 2014 Apr; 34(2):128-34. PubMed ID: 24112388
[TBL] [Abstract][Full Text] [Related]
2. MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.
Wang GB; Liu JH; Hu J; Xue K
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5065-5071. PubMed ID: 29228450
[TBL] [Abstract][Full Text] [Related]
3. Silencing of MGMT with small interference RNA reversed resistance in human BCUN-resistant glioma cell lines.
Xie SM; Fang M; Guo H; Zhong XY
Chin Med J (Engl); 2011 Sep; 124(17):2605-10. PubMed ID: 22040411
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
Kajiyama H; Shibata K; Terauchi M; Yamashita M; Ino K; Nawa A; Kikkawa F
Int J Oncol; 2007 Aug; 31(2):277-83. PubMed ID: 17611683
[TBL] [Abstract][Full Text] [Related]
5. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
6. 4E-BP1 regulates the sensitivity of human glioma cells to chemotherapy through PI3K/Akt/mTOR-independent pathway.
Zhu HL; Xie SM; Fang M; Zhang JJ; Weng ZP; Zhong XY
Neuropathology; 2014 Jun; 34(3):227-35. PubMed ID: 24354477
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
Zheng LT; Lee S; Yin GN; Mori K; Suk K
J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
[TBL] [Abstract][Full Text] [Related]
8. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
9. IGFBP2 induces SPRY1 expression via NF-κB signaling pathway in glioblastoma multiforme (GBM).
Yuan ZS; Cao Y; Li ZY
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5072-5080. PubMed ID: 29228449
[TBL] [Abstract][Full Text] [Related]
10. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
Nam EH; Lee Y; Park YK; Lee JW; Kim S
Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
[TBL] [Abstract][Full Text] [Related]
11. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
[TBL] [Abstract][Full Text] [Related]
12. Deferoxamine enhances cell migration and invasion through promotion of HIF-1α expression and epithelial-mesenchymal transition in colorectal cancer.
Zhang W; Wu Y; Yan Q; Ma F; Shi X; Zhao Y; Peng Y; Wang J; Jiang B
Oncol Rep; 2014 Jan; 31(1):111-6. PubMed ID: 24173124
[TBL] [Abstract][Full Text] [Related]
13. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition.
Zhang X; Li X; Zhang N; Yang Q; Moran MS
Biochem Biophys Res Commun; 2011 Aug; 412(1):188-92. PubMed ID: 21810413
[TBL] [Abstract][Full Text] [Related]
14. Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition.
Wang J; Zhou F; Li Y; Li Q; Wu Z; Yu L; Yuan F; Liu J; Tian Y; Cao Y; Zhao Y; Zheng Y
Cell Cycle; 2017; 16(24):2355-2365. PubMed ID: 29108461
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
16. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation.
Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525
[TBL] [Abstract][Full Text] [Related]
17. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
[TBL] [Abstract][Full Text] [Related]
18. Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display.
Norman SA; Rhodes SN; Treasurywala S; Hoelzinger DB; Rankin Shapiro J; Scheck AC
Cancer; 2000 Aug; 89(4):850-62. PubMed ID: 10951349
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
Yin JH; Yang DI; Chou H; Thompson EM; Xu J; Hsu CY
J Pharmacol Exp Ther; 2001 Apr; 297(1):308-15. PubMed ID: 11259558
[TBL] [Abstract][Full Text] [Related]
20. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
